tradingkey.logo
tradingkey.logo
Search

InfuSystem Holdings Inc

INFU
Add to Watchlist
9.140USD
-0.060-0.65%
Close 07-31 16:00ETQuotes delayed by 15 min
184.46MMarket Cap
23.82P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-31
Previous score
8.50
Change
0
The current earnings forecast score of InfuSystem Holdings Inc is 8.50, ranking 30 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 15.00, with a high of 15.00 and a low of 12.00.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
14.875
Target Price
+52.41%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
InfuSystem Holdings Inc
INFU
4
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is InfuSystem Holdings Inc's expected revenue for the next quarter?

InfuSystem Holdings Inc's expected revenue is 36.35M.

What is InfuSystem Holdings Inc's price target?

Analysts forecast that InfuSystem Holdings Inc's price target is USD 15.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 12.00.

How have InfuSystem Holdings IncINFU's recent earnings per share performed?

The market expectation was USD 0.05, while InfuSystem Holdings IncINFU's earnings per share (EPS) for the previous quarter was USD 0.10. EPS for the next quarter is expected at USD 0.10.

What is the analyst rating for InfuSystem Holdings Inc?

Based on the ratings of InfuSystem Holdings Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.